PhaseRx, Inc. (PZRXQ)
0.0000
0.00 (0.00%)
USD |
OTCM |
Nov 03, 16:00
PhaseRx Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 0.184M |
| November 02, 2026 | 0.184M |
| October 30, 2026 | 0.184M |
| October 29, 2026 | 0.184M |
| October 28, 2026 | 0.184M |
| October 27, 2026 | 0.184M |
| October 26, 2026 | 0.184M |
| October 23, 2026 | 0.184M |
| October 22, 2026 | 0.184M |
| October 21, 2026 | 0.184M |
| October 20, 2026 | 0.184M |
| October 19, 2026 | 0.184M |
| October 16, 2026 | 0.184M |
| October 15, 2026 | 0.184M |
| October 14, 2026 | 0.184M |
| October 13, 2026 | 0.184M |
| October 12, 2026 | 0.184M |
| October 09, 2026 | 0.184M |
| October 08, 2026 | 0.184M |
| October 07, 2026 | 0.184M |
| October 06, 2026 | 0.184M |
| October 05, 2026 | 0.184M |
| October 02, 2026 | 0.184M |
| October 01, 2026 | 0.184M |
| September 30, 2026 | 0.184M |
| Date | Value |
|---|---|
| September 29, 2026 | 0.184M |
| September 28, 2026 | 0.184M |
| September 25, 2026 | 0.184M |
| September 24, 2026 | 0.184M |
| September 23, 2026 | 0.184M |
| September 22, 2026 | 0.184M |
| September 21, 2026 | 0.184M |
| September 18, 2026 | 0.184M |
| September 17, 2026 | 0.184M |
| September 16, 2026 | 0.184M |
| September 15, 2026 | 0.184M |
| September 14, 2026 | 0.184M |
| September 11, 2026 | 0.184M |
| September 10, 2026 | 0.184M |
| September 09, 2026 | 0.184M |
| September 08, 2026 | 0.184M |
| September 04, 2026 | 0.184M |
| September 03, 2026 | 0.184M |
| September 02, 2026 | 0.184M |
| September 01, 2026 | 0.184M |
| August 31, 2026 | 0.184M |
| August 28, 2026 | 0.184M |
| August 27, 2026 | 0.184M |
| August 26, 2026 | 0.184M |
| August 25, 2026 | 0.184M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.177B |
| Athersys, Inc. | -- |
| Oncolytics Biotech, Inc. | 44.94M |
| Sangamo Therapeutics, Inc. | 40.22M |
| Sarepta Therapeutics, Inc. | 2.216B |